Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society

May 1994
Thorax;May1994, Vol. 49 Issue 5, p442
Academic Journal
journal article
No abstract available.


Related Articles

  • A step forward in the evidence-based treatment of opportunist mycobacteria. Ormerod, P. // Thorax;Mar2001, Vol. 56 Issue 3, p163 

    While the treatment of Mycobacterium tuberculosis is firmly based on multiple controlled clinical trials in various settings and meet the criteria for A category recommendations, the management of opportunist mycobacteria other than tuberculosis is much less so. When the Joint Tuberculosis...

  • Multiple drugs.  // Reactions Weekly;Apr2014, Vol. 1495 Issue 1, p35 

    The article presents a case study of a 68-year-old man who developed a pulmonary infection with Mycobacterium intracellulare and disseminated M. avium complex (MAC) infection during treatment with adalimumab, prednisolone, tacrolimus, clarithromycin, ethambutol and rifampicin.

  • Septic Subacromial Bursitis Caused by Mycobacterium kansasii in an Immunocompromised Host. Mathew, Stephanie D.; Tully, Charla C.; Borra, Himabindu; Berven, Michael D.; Arroyo, Ramon // Military Medicine;May2012, Vol. 177 Issue 5, p617 

    Mycobacterium kansasii is a common cause of pulmonary infection as a result of nontuberculous mycobacteria, but is less commonly described as a cause of an orthopedic infection. We present the first case of M. kansasii subacromial septic bursitis in an immunocompromised host. This case...

  • Nontuberculous Mycobacterial Pulmonary Disease in an Immunocompetent Adolescent. Kin-Sun Wong; Tzou-Yien Lin; Yhu-Chering Huang; Chih-Yung Chiu // Respiratory Care;Jul2008, Vol. 53 Issue 7, p908 

    We report a 16-year-old previously healthy boy who presented with a 6-week history of fever, anorexia, weight loss, and respiratory distress. The chest radiograph showed bilateral upper infiltrates and cavitations indistinguishable from Mycobacterium tuberculosis infection. He was actually...

  • Atypical Pneumonia in a Man with Acquired Immunodeficiency Syndrome. Smith, Holly D.; Flenaugh, Eric L. // Clinical Infectious Diseases;8/1/2002, Vol. 35 Issue 3, p334 

    Focuses on patients with endobronchial mycobacteriosis due to Mycobacterium kansasii. Symptoms of Mycobacterium kansasii infection; Treatment; Case of a patient with HIV who developed Mycobacterium kansasii infection.

  • Ethambutol.  // Reactions Weekly;2/27/2010, Issue 1290, p23 

    The article describes the case of a 70-year-old woman who developed chiasmal toxicity with bitemporal hemianopia while receiving treatment with ethambutol for Mycobacterium avium complex and Mycobacterium kansasii infection.

  • Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. Tsukasa Kadota; Hirotoshi Matsui; Takashi Hirose; Junko Suzuki; Minako Saito; Tomohiro Akaba; Kouichi Kobayashi; Shunsuke Akashi; Masahiro Kawashima; Atsuhisa Tamura; Hideaki Nagai; Shinobu Akagawa; Nobuyuki Kobayashi; Ken Ohta; Kadota, Tsukasa; Matsui, Hirotoshi; Hirose, Takashi; Suzuki, Junko; Saito, Minako; Akaba, Tomohiro // BMC Infectious Diseases;1/27/2016, Vol. 16, p1 

    Background: Although the isolation of clarithromycin (CAM)-resistant Mycobacterium avium complex (MAC) indicates a poor treatment outcome and increased mortality, there have been only a few reports on drug treatment for CAM-resistant MAC lung disease. We aimed to reveal the...

  • Infected pulmonary sequestration caused by Mycobacterium kansasii. Lin, S. H.; Lee, L. N.; Chang, Y. L.; Lee, Y. C.; Ding, L. W.; Hsueh, P. R. // Thorax;Apr2005, Vol. 60 Issue 4, p355 

    Presents a letter to the editor related to infected pulmonary sequestration caused by mycobacterium kansasii.

  • Rifampicin/isoniazid/pyrazinamide.  // Reactions Weekly;4/26/2008, Issue 1199, p39 

    The article presents a case study involving a 76-year-old man who developed acute renal failure, thrombocytopenia and leukocytoclastic vasculitis during treatment with rifampicin/isoniazid/pyrazinamide. He started receiving Rifater after being diagnosed with Mycobacterium kansasii pulmonary...

  • Infliximab.  // Reactions Weekly;4/25/2009, Issue 1249, p28 

    The article describes the case of a 53-year-old woman who developed olecranon bursitis secondary to Mycobacterium kansasii infection while under infliximab treatment regimen for Behçet's syndrome. The patient was receiving five milligrams per kilogram (mg/kg) of infliximab every eight weeks,...


Read the Article


Sign out of this library

Other Topics